A hyper-IgM2 AID mutation limits IgH break formation but preserves affinity maturation
Activation-induced cytidine deaminase (AID) drives antibody diversification through class switch recombination (CSR) and somatic hypermutation (SHM). Humans with an AID mutation deleting the last nine amino acids (AID R190X ) develop hyper-IgM syndrome with defective CSR but variable SHM, suggesting that the C terminus plays a marked role in CSR. To model this putative separation-of-function mutation, we generated an Aicda R190X knock-in mouse. These mice show a severe CSR defect and a moderately reduced but ongoing SHM. Mechanistically, the severe CSR defect correlates with defective recombination of double-strand breaks in immunoglobulin switch regions. Strikingly, fusion of AID R190X to a catalytically inactive AID restores CSR, indicating that the C terminus mediates a non-catalytic function for recombination. This mouse model of the human R190X mutation demonstrates that the AID C terminus is indispensable for CSR and also contributes to efficient SHM, providing insight into the mechanistic basis of hyper-IgM immunodeficiency.
Authors
- William Alread
- William T. Yewdell (ORCID: https://orcid.org/0000-0002-5712-1896)
- Jennifer Kimberly Lue (ORCID: https://orcid.org/0000-0001-8153-1820)
- Stephanie Downs‐Canner (ORCID: https://orcid.org/0000-0002-6870-3285)
- Richard L. Frock (ORCID: https://orcid.org/0000-0001-6963-4931)
- Vivian L. S. Kuan (ORCID: https://orcid.org/0000-0001-9547-0467)
- Jayanta Chaudhuri (ORCID: https://orcid.org/0000-0002-3838-0075)
- Kalina T. Belcheva
- Dulguun Baasan
- Priyanka Chowdhury
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- Genentech (US)
- Cornell University (US)
- Stanford Medicine (US)
- Weill Cornell Medicine (US)
- Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences (US)
- Stanford University (US)
Publication Details
- Journal
- Cell Reports
- Published
- 2026-10-30
- DOI
- https://doi.org/10.1016/j.celrep.2026.118221
- Primary Topic
- DNA Repair Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Cancer Institute
- Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases